PNP and prostate cancer: miR-1 was found to target the oncogene purine nucleoside phosphorylase (PNP) in prostate cancer, thus suppressing cell migration and invasion, in agreement with the effects of PNP silencing in prostate cancer lines PC3 and DU145 [125].